How do you convert from co-beneldopa (Madopar®) prolonged-release capsules to dispersible tablets?

For patients taking the prolonged-release preparation of co-beneldopa (Madopar® CR), there may be clinical situations when an alternative formulation of co-beneldopa needs to be considered e.g. if swallowing difficulties develop. Co-beneldopa dispersible tablets (Madopar® Dispersible) are the formulation of choice for patients who are no longer able to swallow the prolonged-release capsules.

This Medicines Q&A discusses how to convert from Madopar CR capsules to the dispersible tablets.